Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus

Autor: Vignesh Sadras, Michelle Petri, Subroto Chatterjee, Barbara Lee Peterlin, Steven R. Jones
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Apolipoprotein B
chemistry.chemical_compound
0302 clinical medicine
systemic lupus erythematosus
Risk Factors
Lupus Erythematosus
Systemic

Systemic lupus erythematosus
music.instrument
biology
Biomarker Studies
General Medicine
Glycosphingolipid
Middle Aged
Galactosyltransferases
Antibodies
Antiphospholipid

Female
medicine.symptom
Antibody
Adult
lcsh:Immunologic diseases. Allergy
medicine.medical_specialty
Immunology
Lactosylceramides
Enzyme-Linked Immunosorbent Assay
Inflammation
lipids
03 medical and health sciences
Lactosylceramide
Antigen
Internal medicine
medicine
Humans
music
030203 arthritis & rheumatology
business.industry
Atherosclerosis
medicine.disease
030104 developmental biology
Endocrinology
chemistry
inflammation
Case-Control Studies
Baltimore
biology.protein
business
lcsh:RC581-607
Lipoprotein(a)
Lipoprotein
Zdroj: Lupus Science and Medicine, Vol 7, Iss 1 (2020)
Lupus Science & Medicine
ISSN: 2053-8790
Popis: Objectiveβ-1,4 galactosyltransferase-V (β-1,4 GalT-V) is an enzyme that synthesises a glycosphingolipid known as lactosylceramide, which has been implicated in general inflammation and atherosclerosis. We asked if β-1,4 GalT-V was present at elevated levels in patients with SLE, a disease which is associated with increased risk of atherosclerosis.MethodsIn this case–control observational study, serum samples were obtained from patients with SLE who are part of the Johns Hopkins Lupus Cohort. Control serum samples were obtained from healthy adult community members recruited from the Baltimore area. All serum samples (n=50 in the SLE group and n=50 in the healthy control group) were analysed with enzyme-linked immunoassays. These assays used antibodies raised against antigens that enabled us to measure the absorbance of oxidised phosphocholines per apolipoprotein B-100 (ox-PC/apoB) and the concentration of lipoprotein(a) (Lp(a)) and β-1,4 GalT-V.ResultsAbsorbance of ox-PC/apoB and concentrations of Lp(a) and β-1,4 GalT-V were significantly higher in the SLE serum samples as compared with the control serum (pConclusionsWe conclude that patients with SLE have elevated levels of β-1,4 GalT-V and ox-PC, which have previously been recognised as risk factors for atherosclerosis.
Databáze: OpenAIRE